UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013506
Receipt number R000015782
Scientific Title Analysis of marker assoriated with iron and inflammation in allogeneic cell transplantation: multicenter prospecitve study
Date of disclosure of the study information 2014/03/25
Last modified on 2017/01/04 15:47:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of marker assoriated with iron and inflammation in allogeneic cell transplantation: multicenter prospecitve study

Acronym

II-HCT

Scientific Title

Analysis of marker assoriated with iron and inflammation in allogeneic cell transplantation: multicenter prospecitve study

Scientific Title:Acronym

II-HCT

Region

Japan


Condition

Condition

Hematologic disease

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the prognostic significance of iron and inflammation markers in allogeneic cell transplantation

Basic objectives2

Others

Basic objectives -Others

To evaluated the clinical significance of iron and inflammation markers in post-transplant period.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

overall survival at 2 year according to makers

Key secondary outcomes

(1)disease-free survival, non-relapse mortality, and relapse at 2 year according to makers
(2)corelation between ferritin and other markers
(3)relation between markers and transplant-related complications


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1)age more than 16 year old
(2)First allogeneic cell transplantaion
(3)acute leukemia, myelodysplastic syndrome, aplastic anemia, chronic leukemia, adult T-cell leukemia/lymphoma, malicnant lynphoma, multiple myeloma
(4)informed consent

Key exclusion criteria

(1)history of allogeneic cell transplantation
(2) decised unsuitable by associated doctor

Target sample size

140


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takayoshi Tachibana

Organization

Yokohama City University

Division name

Internal medicine and clinical immunology

Zip code


Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Japan

TEL

045-787-2800

Email

tcbnt@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takayoshi Tachibana

Organization

Yokohama City University

Division name

Internal medicine and clinical immunology

Zip code


Address

3-9 Fukuura, Kanazawa-ku, Yokohama, Japan

TEL

045-787-2800

Homepage URL


Email

tcbnt@yokohama-cu.ac.jp


Sponsor or person

Institute

Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate of School of Medicine, Yokohama, Japan

Institute

Department

Personal name



Funding Source

Organization

NA

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 03 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2014 Year 03 Month 20 Day

Date of IRB


Anticipated trial start date

2014 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Under registration


Management information

Registered date

2014 Year 03 Month 25 Day

Last modified on

2017 Year 01 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015782


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name